Back
Top 35%
19.0%
#1
19.0%
Top 24%
8.4%
Top 26%
6.4%
Top 2%
5.4%
Top 15%
3.0%
Top 35%
2.1%
Top 14%
2.1%
Top 11%
2.1%
Top 8%
2.1%
Top 19%
1.6%
Top 13%
1.0%
Top 16%
0.8%
Top 8%
0.8%
Top 19%
0.8%
Top 3%
0.8%
Top 10%
0.8%
A Case of Excessive, Opportunistic Price Increase of a Generic Oncology Drug
2025-07-06
health policy
Title + abstract only
View on medRxiv
Show abstract
BackgroundOff-patent, generic drugs are expected to be widely accessible owing competitive pricing and minimal R&D costs. Sudden, excessive, unexplainable, and sustained price increases detrimentally impact the health and welfare of patients and their families. Overlooking such cases encourages repeat behavior that may be legislatively challenging to overcome, thereby impeding the principle of democratization of medicines propagated by the expiration of patent protection. FindingsWe analyzed Me...
Predicted journal destinations
1
PLOS ONE
1737 training papers
2
JAMA Network Open
125 training papers
3
Scientific Reports
701 training papers
4
BMJ Open
553 training papers
5
Vaccines
131 training papers
6
eLife
262 training papers
7
Nature Communications
483 training papers
8
Frontiers in Public Health
135 training papers
9
International Journal of Environmental Research and Public Health
116 training papers
10
Journal of Medical Internet Research
81 training papers
11
BMC Public Health
148 training papers
12
Open Forum Infectious Diseases
124 training papers
13
Nature Medicine
88 training papers
14
JMIR Public Health and Surveillance
45 training papers
15
Proceedings of the National Academy of Sciences
100 training papers
16
F1000Research
28 training papers
17
Vaccine
140 training papers